Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, for the ACCESS Study Group, Pierre‐François Laterre et al.|JAMA|2013Cited by 797
A comparison of very old patients admitted to intensive care unit after acute versus elective surgery or interventionChristian Jung, Hans Flaatten, Steffen Christensen et al.|Journal of Critical Care|2019Cited by 63
Steroid use in elderly critically ill COVID-19 patientsChristian Jung, Hans Flaatten, Bernhard Wernly et al.|European Respiratory Journal|2021Cited by 60
Noninvasive ventilation in COVID-19 patients aged ≥ 70 years—a prospective multicentre cohort studyKamil Polok, Hazem Abosheaishaa, Jakub Fronczek et al.|Critical Care|2022Cited by 19
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, Daniel P. Rossignol, Pierre‐François Laterre et al.|Unknown|2013Cited by 7